Depression Devices Market to Expand at a Robust Pace Through 2029, Driven by Rising Prevalence of Treatment-Resistant Depression and Demand for Non-Pharmacological Therapies
Benzodiazepine Drugs Market to Expand at a CAGR of 3.0% Through 2035, Driven by Rising Prevalence of Anxiety, Insomnia, and Growing Geriatric Population